These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 409640)

  • 1. The direct effect of hypoglycaemic sulphonylureas on myocardial contractile force and arterial blood pressure.
    Pogátsa G; Dubecz E
    Diabetologia; 1977 Sep; 13(5):515-9. PubMed ID: 409640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct effect of hypoglycemic sulphonylureas on the cardiovascular system of dogs.
    Ballagi-Pordány G; Koltai MZ; Aranyi Z; Pogátsa G
    Diabetes Res Clin Pract; 1991 Jan; 11(1):47-52. PubMed ID: 2019235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic and metabolic effects of low daily dose sulphonylureas in diabetic dog hearts.
    Pósa I; Kocsis E; Nieszner E; Pogátsa G; Koltai MZ
    Arzneimittelforschung; 2002; 52(7):552-9. PubMed ID: 12189779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of hypoglycaemic sulphonylureas on rabbit heart.
    Pogátsa G; Németh M
    Eur J Pharmacol; 1980 Oct; 67(4):333-8. PubMed ID: 6778701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of conventional sulfonylureas and glimepiride.
    Geisen K; Végh A; Krause E; Papp JG
    Horm Metab Res; 1996 Sep; 28(9):496-507. PubMed ID: 8911987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of oral hypoglycemic agents, gliclazide and tolbutamide, on the cardiovascular system (author's transl)].
    Maekawa H; Yamamoto J; Kato Y; Sekiya A
    Nihon Yakurigaku Zasshi; 1978 Jul; 74(5):549-58. PubMed ID: 700517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats.
    Katsumata K; Katsumata Y
    Horm Metab Res; 1990 Jan; 22(1):51-2. PubMed ID: 2106472
    [No Abstract]   [Full Text] [Related]  

  • 8. Gliclazide- and glibenclamide-mediated transport of Pr3+ across an artificial lipid membrane.
    Deleers M; Gelbcke M; Malaisse WJ
    Arch Int Pharmacodyn Ther; 1983 Apr; 262(2):313-4. PubMed ID: 6409019
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro metabolic effects of gliclazide and glibenclamide in the rat.
    Musbah MO; Furman BL
    J Pharm Pharmacol; 1980 Aug; 32(8):550-3. PubMed ID: 6106691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The failure of oxygen breathing to decrease the myocardial contractile force in denervated dogs.
    Ishikawa K; Kanamasa K; Yamakado T; Kohashi Y; Katori R
    Jpn Circ J; 1983 Jul; 47(7):824-9. PubMed ID: 6864987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract]   [Full Text] [Related]  

  • 12. Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds.
    Ballagi-Pordány G; Köszeghy A; Koltai MZ; Aranyi Z; Pogátsa G
    Diabetes Res Clin Pract; 1990 Jan; 8(2):109-14. PubMed ID: 2106423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral hypoglycaemic agents on platelet functions.
    Ozaki Y; Yatomi Y; Kume S
    Biochem Pharmacol; 1992 Aug; 44(4):687-91. PubMed ID: 1510715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the sulphonylurea drugs gliclazide and glibenclamide on blood glucose control and platelet function.
    Klaff LJ; Vinik AI; Jackson WP; Malan E; Kernoff L; Jacobs P
    S Afr Med J; 1979 Aug; 56(7):247-50. PubMed ID: 121645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene networks modified by sulphonylureas in beta cells: a pathway-based analysis of insulin secretion and cell death.
    Magnusson NE; Dyrskjøt L; Grimm D; Wehland M; Pietsch J; Rungby J
    Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):254-61. PubMed ID: 22642398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of arterial baroreceptors in mediating the cardiovascular response to a cardiac glycoside in conscious dogs.
    McRitchie RJ; Vatner SF
    Circ Res; 1976 Apr; 38(4):321-6. PubMed ID: 1260975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population.
    Juurlink DN; Gomes T; Shah BR; Mamdani MM
    Diabet Med; 2012 Dec; 29(12):1524-8. PubMed ID: 22913620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of L-dopa on myocardial contractile force: a reappraisal.
    Wenger JJ; Osborne MW
    Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):251-6. PubMed ID: 1190920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of diazepam and chlordiazepoxide.
    Daniell HB
    Eur J Pharmacol; 1975 May; 32(1):58-65. PubMed ID: 1149828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of gliclazide and glibenclamide on platelet function, fibrinolysis and metabolic control in diabetic patients with retinopathy (author's transl)].
    Chan TK; Chan V; Teng CS; Yeung RT
    Sem Hop; 1982 May; 58(19):1197-200. PubMed ID: 6285503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.